Indian Pharma Firms Introduce Generic Semaglutide Injections For Diabetes & Obesity Treatment
Indian drugmakers launch affordable semaglutide injections after patent expiry, expanding access for diabetes and obesity patients across the country.
Indian drugmakers launch affordable semaglutide injections after patent expiry, expanding access for diabetes and obesity patients across the country.
